Capsular Serotyping of Streptococcus pneumoniae by latex agglutination

Barbara D Porter1, Belinda D Ortika1, Catherine Satzke2

  • 1Pneumococcal Research, Murdoch Childrens Research Institute.

Insights

This study details a cost-effective method for producing and quality-controlling latex agglutination reagents for identifying Streptococcus pneumoniae serotypes. This approach aids in epidemiological surveillance and vaccine impact assessment, especially in resource-limited settings.

Area of Science:

  • Microbiology
  • Immunology
  • Diagnostic Assays

Background:

  • Streptococcus pneumoniae causes significant global morbidity and mortality.
  • Pneumococcal vaccines target over 90 capsular serotypes, necessitating accurate serotyping for epidemiological surveillance and vaccine program evaluation.
  • Latex agglutination is recommended by the WHO as a practical alternative to the Quellung test for pneumococcal serotyping.

Purpose of the Study:

  • To describe a method for the in-house production and quality control of latex agglutination reagents.
  • To present a time- and cost-effective sequential testing strategy for pneumococcal serotyping.
  • To offer a scalable method applicable to various diagnostic testing needs.

Main Methods:

  • Passive attachment of commercially sourced antibodies to latex particles for reagent preparation.
  • Implementation of a sequential testing algorithm for efficient serotyping.
  • Establishment of quality control measures for reagent production.

Main Results:

  • A reproducible method for producing functional latex agglutination reagents was established.
  • The sequential testing approach demonstrated efficiency in terms of time and cost.
  • The developed method is suitable for both high-volume laboratories and resource-poor settings.

Conclusions:

  • The described method provides a reliable and economical means for producing latex agglutination reagents for pneumococcal serotyping.
  • This approach supports accurate epidemiological monitoring and assessment of vaccine effectiveness.
  • The production and quality control methodology may be adaptable for other microbial diagnostic applications.